TTM Technologies (NASDAQ: TTMI) hits $1B Q2 sales, sees about $4.4B in 2026
Rhea-AI Filing Summary
TTM Technologies reported record Q2 2026 results, with net sales of $1.0 billion, up 37% year-over-year from $731 million, and non-GAAP EPS of $0.99, both above guidance and all-time quarterly highs. Growth was driven by Data Center & Networking, which represented 40% of sales and grew 91% year-over-year, alongside strong contributions from Aerospace & Defense and Medical, Industrial & Instrumentation.
Profitability improved meaningfully. Non-GAAP gross margin was 21.9% and operating margin 13.8%, while Adjusted EBITDA reached $166.8 million, a 16.6% margin compared with 15.0% a year earlier. Aerospace & Defense posted a book-to-bill of 1.3, supporting backlog of $1.7 billion and a qualified pipeline exceeding $7 billion. Overall Q2 book-to-bill was 1.49, and the 90-day backlog rose to $901 million, up 81% year-over-year.
Outlook was raised and remains growth-focused. Management projects Q3 2026 net sales of $1.10–$1.14 billion and non-GAAP EPS of $1.21–$1.27, and now expects full-year 2026 sales of approximately $4.4 billion with non-GAAP EPS approaching $5, excluding pending European acquisitions. The company targets 15%–20% organic revenue growth in 2027 and 2028 and reports a net leverage ratio of 0.9 times.
Positive
- Q2 2026 net sales rose 37% to $1.0 billion, with non-GAAP EPS up 71% to $0.99, both all-time quarterly highs above guidance.
- 2026 outlook was strengthened, with expected sales of approximately $4.4 billion and non-GAAP EPS approaching $5, excluding pending acquisitions, plus targeted 15%–20% organic revenue growth for 2027–2028.
- Demand in AI-driven data centers and defense is robust, supporting a Q2 book-to-bill of 1.49, Aerospace & Defense backlog of $1.7 billion, and a 90-day backlog of $901 million.
Negative
- None.
Filing Explained
The amendment adds a planned $600 million second-half M+N program and about $45 million of additional 2026 capital spending.
This Form 8-K/A adds the full August 5 conference-call transcript as Exhibit 99.2, while stating that the earlier report otherwise remains unchanged. TTM Technologies says its proposed acquisitions of Swiss Technology Group AG and ILFA GmbH remain subject to regulatory review and are expected to close in the third quarter; management expects less than
The transcript describes about
Management also said accelerated capital spending had been approved, increasing the expected 2026 spending range by around
The transcript does not disclose the acquisition consideration or detailed closing conditions; regulatory review and the expected third-quarter closing are the identified milestones for resolving those uncertainties.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
book-to-bill financial
Ultra-HDI technical
deal contingent cross-currency swap financial
non-GAAP financial measures financial
Earnings Snapshot
For Q3 2026, projected net sales of $1.10–$1.14 billion and non-GAAP EPS of $1.21–$1.27 per diluted share. For full year 2026, expects approximately $4.4 billion in sales and non-GAAP EPS approaching $5, excluding contributions or impacts from pending acquisitions.
AI-generated analysis. How Rhea-AI works. Not financial advice.